Gulf International Bank (UK)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.53M Buy
157,160
+56,073
+55% +$3.27M 0.21% 82
2025
Q4
$5.45M Hold
101,087
0.18% 101
2025
Q3
$4.56M Sell
101,087
-2,005
-2% -$93.6K 0.15% 126
2025
Q2
$4.77M Sell
103,092
-15,588
-13% -$765K 0.17% 113
2025
Q1
$7.24M Sell
118,680
-42,706
-26% -$2.49M 0.25% 81
2024
Q4
$9.13M Sell
161,386
-1,686
-1% -$94.2K 0.23% 79
2024
Q3
$8.44M Sell
163,072
-106
-0.1% -$4.97K 0.22% 92
2024
Q2
$6.78M Sell
163,178
-10,222
-6% -$457K 0.17% 115
2024
Q1
$9.4M Buy
173,400
+709
+0.4% +$36.1K 0.24% 91
2023
Q4
$8.86M Sell
172,691
-19,652
-10% -$1.03M 0.25% 84
2023
Q3
$11.2M Sell
192,343
-20,363
-10% -$1.25M 0.32% 57
2023
Q2
$13.6M Sell
212,706
-67,305
-24% -$4.51M 0.34% 54
2023
Q1
$19.4M Sell
280,011
-80,695
-22% -$5.69M 0.41% 49
2022
Q4
$26M Buy
360,706
+225
+0.1% +$17K 0.46% 42
2022
Q3
$25.6M Sell
360,481
-8,406
-2% -$610K 0.48% 38
2022
Q2
$28.9M Hold
368,887
0.51% 39
2022
Q1
$26.9M Buy
368,887
+600
+0.2% +$40.3K 0.4% 50
2021
Q4
$23M Sell
368,287
-77,180
-17% -$4.53M 0.32% 61
2021
Q3
$26.4M Sell
445,467
-6,030
-1% -$397K 0.34% 58
2021
Q2
$30.2M Sell
451,497
-293
-0.1% -$19.1K 0.38% 51
2021
Q1
$28.5M Sell
451,790
-51,018
-10% -$3.17M 0.39% 56
2020
Q4
$31.2M Sell
502,808
-36,446
-7% -$2.24M 0.41% 53
2020
Q3
$32.5M Sell
539,254
-3,346
-0.6% -$201K 0.46% 48
2020
Q2
$31.9M Sell
542,600
-17,260
-3% -$1.03M 0.49% 44
2020
Q1
$31.2M Buy
559,860
+10,226
+2% +$625K 0.59% 34
2019
Q4
$35.3M Buy
549,634
+161,922
+42% +$9.27M 0.54% 36
2019
Q3
$19.7M Sell
387,712
-2,452
-0.6% -$115K 0.33% 65
2019
Q2
$17.7M Sell
390,164
-1,953
-0.5% -$91K 0.3% 68
2019
Q1
$18.7M Buy
392,117
+2,005
+0.5% +$99.9K 0.33% 66
2018
Q4
$20.3M Sell
390,112
-168,784
-30% -$9.07M 0.4% 55
2018
Q3
$34.7M Buy
558,896
+29,633
+6% +$1.76M 0.41% 55
2018
Q2
$29.3M Buy
529,263
+13,750
+3% +$743K 0.37% 60
2018
Q1
$32.6M Sell
515,513
-3,542
-0.7% -$228K 0.42% 50
2017
Q4
$31.8M Hold
519,055
0.4% 49
2017
Q3
$33.1M Sell
519,055
-900
-0.2% -$52.6K 0.45% 46
2017
Q2
$29M Buy
519,955
+800
+0.2% +$43.5K 0.41% 48
2017
Q1
$28.2M Buy
519,155
+8,065
+2% +$442K 0.41% 44
2016
Q4
$29.9M Buy
511,090
+3,500
+0.7% +$191K 0.46% 42
2016
Q3
$27.4M Buy
507,590
+3,950
+0.8% +$254K 0.44% 46
2016
Q2
$37M Hold
503,640
0.62% 32
2016
Q1
$32.2M Buy
503,640
+6,970
+1% +$440K 0.54% 38
2015
Q4
$34.2M Buy
496,670
+11,350
+2% +$750K 0.59% 34
2015
Q3
$28.7M Buy
485,320
+9,190
+2% +$583K 0.54% 36
2015
Q2
$31.7M Buy
476,130
+904
+0.2% +$59.6K 0.55% 39
2015
Q1
$30.7M Buy
475,226
+667
+0.1% +$41.8K 0.55% 39
2014
Q4
$28M Buy
474,559
+5,600
+1% +$316K 0.5% 43
2014
Q3
$24M Buy
468,959
+8,008
+2% +$400K 0.44% 46
2014
Q2
$22.4M Hold
460,951
0.41% 49
2014
Q1
$23.9M Buy
460,951
+5,892
+1% +$314K 0.47% 44
2013
Q4
$24.2M Buy
+455,059
New +$23.2M 0.48% 43

Other funds holding BMY

Gulf International Bank (UK)'s BMY Position: Q1 2026 in Review

Gulf International Bank (UK) increased its Bristol-Myers Squibb (BMY) stake by 55% in Q1 2026, buying an estimated $3.27M and bringing the position to 157,160 shares worth $9.53M. The position accounts for 0.21% of the portfolio, ranked #82.

Gulf International Bank (UK) first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $37M in Q2 2016. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Gulf International Bank (UK) held 157,160 shares of Bristol-Myers Squibb worth $9.53M as of Q1 2026.
  • Gulf International Bank (UK) bought 56,073 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.27M.
  • Bristol-Myers Squibb made up 0.21% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #82 holding.
  • Gulf International Bank (UK) first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
  • Gulf International Bank (UK)'s Bristol-Myers Squibb position peaked at $37M in Q2 2016.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.